These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5334964)

  • 21. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunoserological research in Hodgkin's disease].
    Schächter A; Sărăţeanu D; Cepleanu M; Cajal N; Sorodoc I
    Med Interna (Bucur); 1966 Nov; 18(11):1359-66. PubMed ID: 6009917
    [No Abstract]   [Full Text] [Related]  

  • 23. Circulating lymphoid cells in Hodgkin's disease.
    Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():95-8. PubMed ID: 4270378
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunologic changes in patients with Hodgkin's disease in clinical remission and recurrence].
    Ares BR; Sasiain MD; Brezavscek DM; Fejes M; Bachmann AE
    Medicina (B Aires); 1981; 41(3):287-92. PubMed ID: 6275237
    [No Abstract]   [Full Text] [Related]  

  • 25. Anergy and skin homograft survival in Hodgkin's disease.
    KELLY WD; GOOD RA; VARCO RL
    Surg Gynecol Obstet; 1958 Nov; 107(5):565-70. PubMed ID: 13592655
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diseases with disturbance of the cell-bound immunity reaction].
    Huber H
    Wien Klin Wochenschr; 1967 Nov; 79(47):868-72. PubMed ID: 4876220
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: Transfer of cell-mediated skin reactivity with "immune" RNA in Hodgkin's disease and other neoplastic diseases.
    Han T
    Cancer; 1974 Feb; 33(2):497-502. PubMed ID: 4130298
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 30. Transplantation immunity and delayed cutaneous hypersensitivity reactions in dogs.
    Streilein JW; Barker CF
    J Immunol; 1967 Mar; 98(3):601-8. PubMed ID: 5335975
    [No Abstract]   [Full Text] [Related]  

  • 31. [In vivo studies, using the skin-window technic, on the inflammatory cellular reactivity in hodgkin's disease].
    Maglulo E; Carcò FP; Giraldi M; Sprovieri G
    Arch De Vecchi Anat Patol; 1967 Dec; 50(3):615-27. PubMed ID: 4951032
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cellular immunity and clinico-histological stage in Hodgkin's disease].
    Fabris C; De Sanctis C; Ciriotti G; Ponzone A
    Minerva Pediatr; 1971 Feb; 23(5):190-3. PubMed ID: 5574421
    [No Abstract]   [Full Text] [Related]  

  • 33. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
    Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current immunologic data on Hodgkin's disease].
    Weisgerber C; Kourilsky FM
    Rev Prat; 1974 Oct; 24(45):3927-9. PubMed ID: 4445766
    [No Abstract]   [Full Text] [Related]  

  • 35. Delayed cutaneous hypersensitivity testing in untreated Hodgkin's disease using a standardized new device.
    Lang JM; Giron C; de Leon J; Oberling F
    Biomedicine; 1980 May; 33(3):62-4. PubMed ID: 7448324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
    Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
    Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tumor antigens in Hodgkin's lymphogranuloma].
    Antonaci S; Tribalto M; Mandelli F; Dammacco F
    Recenti Prog Med; 1976 Aug; 61(2):211-8. PubMed ID: 1037142
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune deficiency in Hodgkin and non-Hodgkin lymphoma.
    El-Haddad SI; El-Ashmawy S; Hassan W; George E; Ali FM; Sharaf MA; Mahfouz M
    Biomedicine; 1980 Oct; 32(3):128-33. PubMed ID: 7448322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Late hypersensitivity of the skin to DNCB in patients with Hodgkin's disease].
    Dziewulska-Bokiniec A; Lapińska M
    Nowotwory; 1980; 30(2):149-54. PubMed ID: 7413448
    [No Abstract]   [Full Text] [Related]  

  • 40. The absence of lymphocyte response in vitro to tuberculin challenge in Hodgkin's disease.
    Sartoris S; Cavallero P; Pegoraro L; Vergnano F; Fazio M
    Panminerva Med; 1965 Oct; 7(10):370-2. PubMed ID: 5844508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.